Stay updated with breaking news from Nasdaq Thrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) saw a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 1,440,000 shares, an increase of 25.2% from the June 15th total of 1,150,000 shares. Currently, 9.5% of the company’s stock are short sold. Based on an […]
Shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) rose 0.7% on Tuesday . The stock traded as high as $10.26 and last traded at $10.04. Approximately 78,289 shares traded hands during mid-day trading, a decline of 64% from the average daily volume of 214,724 shares. The stock had previously closed at $9.97. Wall […]
Theseus Pharmaceuticals (NASDAQ:THRX – Get Free Report) had its target price lowered by research analysts at HC Wainwright from $22.00 to $9.00 in a report released on Friday, FlyOnTheWall reports. HC Wainwright’s target price indicates a potential downside of 5.46% from the stock’s current price. Theseus Pharmaceuticals Stock Down 3.7 % NASDAQ THRX opened at […]
Theseus Pharmaceuticals (NASDAQ:THRX – Get Free Report) had its price objective dropped by stock analysts at HC Wainwright from $22.00 to $9.00 in a research report issued to clients and investors on Friday, FlyOnTheWall reports. HC Wainwright’s target price suggests a potential downside of 5.46% from the company’s previous close. Theseus Pharmaceuticals Trading Down 3.7 […]
Opaleye Management Inc. grew its stake in shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Rating) by 142.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 535,000 shares of the company’s stock after buying an additional 314,350 shares during the period. Opaleye Management Inc.’s holdings in Theseus […]